IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF

Inventiva S.A.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026

$2.98+0.04 (+1.36%)

Close on Oct 19, 2026

Inventiva S.A. balance sheet

Annual Quarterly

EUR USD

Millions of EUR, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Cash & Equivalents	99	97	27	87	87	106	36	57	59
Cash & Short-Term Investments	99	97	27	87	87	106	36	57	59
Receivables	2.02	0.53	3.81	0	4.00	0.05	0.00	0.01	–
Inventory	–	0	0.42	0.37	0.39	0.32	0.39	0.41	–
Other Current Assets	141	9.48	12	13	20	18	2.81	5.09	–
Total Current Assets	244	112	48	106	116	133	49	72	–
Property, Plant & Equipment	–	5.01	9.13	7.39	3.20	3.28	3.72	4.51	4.52
Intangible Assets	0.18	0.05	0.54	0.57	0.77	0.94	1.23	1.54	1.81
Deferred Tax Assets	0.19	0.22	0.23	0	0	0	0	–	–
Other Long-Term Assets	1.16	1.05	10	1.67	2.44	1.71	3.14	2.37	–
Total Assets	250	119	70	116	122	139	57	80	–
Accounts Payable	26	33	38	19	15	6.92	7.49	–	–
Short-Term Debt	–	–	–	–	–	0.02	0.11	0.15	–
Current Debt	–	–	–	5.85	1.28	0.02	0.11	0.15	–
Other Current Liabilities	18	8.60	7.17	5.49	6.79	6.84	5.00	4.87	–
Total Current Liabilities	77	121	50	31	23	14	14	15	–
Long-Term Debt	–	–	–	29	8.84	10	0.00	0.07	–
Operating Lease Liabilities	2.77	4.65	6.57	4.51	0.13	0.00	0.04	–	–
Other Long-Term Liabilities	1.19	1.03	1.03	–	–	–	–	–	–
Total Liabilities	278	226	102	71	33	28	16	18	–
Total Debt	–	–	–	35	10	10	0.12	0.23	–
Common Stock	1.93	0.96	0.52	0.42	0.41	0.39	0.27	0.22	–
Additional Paid-In Capital	528	249	202	174	165	140	86	77	–
Retained Earnings	–	–	–	–	–	-34	-30	-33	–
Total Equity	-29	-107	-32	45	89	111	41	62	61
Total Liabilities & Equity	250	119	70	116	122	139	57	80	–
Shares Outstanding(shares)	193	96	52	42	41	39	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: -3145.5%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 3.81
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 257.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.